此页面是自动翻译的，不保证翻译的准确性。请参阅 英文版 对于源文本。

Young People and Illness Management and Recovery (IMR)

2022年9月29日 更新者：Anne-Lise Holmesland、University Hospital, Akershus

Young People's Experiences of Illness Management and Recovery (IMR) - an Explorative Study

The study is a combined clinical patient outcome study and a health-services research sub-study. Illness management and recovery (IMR) constitutes an evidence-based practice with 11 modules focusing on personal recovery developed for adults with severe mental health illnesses. IMR can be offered in groups or individually, once a week for 10-12 months.

Little is known about how young people experience the utility of IMR treatment groups in child and adolescent mental health outpatient clinics. The primary aim is to explore in-depth how the participants experience the utility of the IMR approach. The health research sub-study will provide new insights into the IMR implementation process in outpatient clinics for adolescents.

研究概览

地位

终止

条件

干预/治疗

详细说明

IMR has previously been implemented for adolescents in an inpatient unit in the hospital's catchment area. In order to offer the same treatment to all young patients, IMR treatment groups will be established in 4 out of 7 outpatient clinics in the hospital's catchment area. Participants belonging to the clinics in which no IMR treatment groups are being established will be invited to participate in IMR groups in clinics nearby.

The primary aim is to gain new insight into how young people experience the utility of IMR treatment groups conducted in outpatient practices and, if relevant, which changes could be made to adapt IMR more to young people. To explore how the participants experience the utility of IMR treatment groups, a qualitative focus-group study, consisting of a maximum of 5 focus-group interviews will be conducted. The participants in each IMR treatment group will be offered treatment once a week up to 10-12 months. To establish an IMR treatment group a minimum of 4 patients and a maximum of 8 participants must participate. Participants are mainly being included in the IMR treatment groups at the two primary admissions to each treatment group. Thus, some of the participants in the focus-groups may have participated in IMR groups for less than 10-12 months.

Secondary outcomes are related to fidelity to the model and the extent to which IMR treatment groups are implemented at an organizational level. The treatment groups will be led by trained IMR-therapists employed in inpatient units, together with therapists in training who are employed in outpatient clinics. Leaders and other clinicians in the outpatient clinics will contribute knowledge about the extent to which core components of IMR are being implemented, as well as information relating to quality improvement and individual adjustment. Two of the out-patient clinics in which no IMR group is being established will be included in the sub-study. The clinics will receive written feedback after each measurement time to support quality improvement.

The goal is to include up to 48 participants receiving IMR treatment in outpatient clinics. Up to 8 hospitalized participants will participate in a pilot focus-group interview. In the sub-study, a maximum of 16 IMR therapists, trained and in training, and up to 24 staff members will be invited to participate.

研究类型

观察性的

注册 (实际的)

10

联系人和位置

本节提供了进行研究的人员的详细联系信息，以及有关进行该研究的地点的信息。

学习地点

  • 挪威
      • Viken、挪威
        • Akershus universitetssykehus

参与标准

研究人员寻找符合特定描述的人，称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

13年 至 17年 (孩子)

接受健康志愿者

不

有资格学习的性别

全部

取样方法

非概率样本

研究人群

Patients between 13-17 years of age suffering from or having symptoms of psychosis or bipolar disorders, and who participate in an IMR treatment group at one of the 4 (out of 7) outpatient clinics in the hospitals catchment area, and who are able to give informed consent. Up to 8 inpatients or previous inpatients between 13- 17 years of age suffering from various diagnoses will be invited to participate in a pilot focus-group interview. Trained clinicians and clinicians in training contribute to the implementation in the outpatient clinics together with clinic leaders and other clinicians.

描述

Inclusion Criteria Patients:

Outpatient units:

  • Included in the IMR group in one of the outpatient clinics
  • Able to give informed consent

Inpatient unit (focus group):

  • 13-17 years of age
  • Current or previous patient
  • Able to understand and speak Norwegian
  • Able to give informed consent

Exclusion criteria (inpatient unit)

  • Younger than 13 years
  • Mental retardation
  • Manic phase

Inclusion Criteria: IMR therapists:

  • IMR therapist leading IMR treatment groups in one of the participating outpatient clinics
  • Trained or training in IMR
  • Employed at the Department for Child and Adolescent Mental Health Services at Akershus University Hospital.

Inclusion Criteria: Other staff members

• Employed at the Department for Child and Adolescent Mental Health Services at Akershus University Hospital.

学习计划

本节提供研究计划的详细信息，包括研究的设计方式和研究的衡量标准。

研究是如何设计的？

设计细节

队列和干预

团体/队列
干预/治疗
IMR patients
Patients from outpatient clinics receiving IMR from trained IMR therapists and IMR therapists in training.
行为的：Illness management and recovery
Treatment given in groups, weekly for 10-12 months.
其他名称：
  • IMR
IMR therapists and other staff
Clinic leaders, IMR therapists and other staff participating in semi-structured individual or group interviews.
其他：Semi-structured interviews
Semi-structured individual or group interviews conducted three times with staff on each participating outpatient clinic.

研究衡量的是什么？

主要结果指标

结果测量
措施说明
大体时间
Focus-group interview aiming to explore the significance of the participant's own understanding of and knowledge about the disorder.
大体时间：End of treatment group, on average 11 months.
Focus-group interviews when the treatment group has come to an end aimed at exploring different perspectives on IMR treatment.
End of treatment group, on average 11 months.
Focus-group interview aiming to explore the impact of the IMR treatment on dealing with everyday life.
大体时间：End of treatment group, on average 11 months.
Focus-group interviews when the treatment group has come to an end aimed at exploring different perspectives on IMR treatment.
End of treatment group, on average 11 months.
Focus-group interview aiming to explore the importance of meeting other young people in the same situation.
大体时间：End of treatment group, on average 11 months.
Focus-group interviews when the treatment group has come to an end aimed at exploring different perspectives on IMR treatment.
End of treatment group, on average 11 months.

次要结果测量

结果测量
措施说明
大体时间
The Illness Management and Recovery Scale (IMRS)
大体时间：Baseline (0 months), 6 and 12 months.
A 15-item scale that assesses illness self-management on a 5-point Likert scale where 5 indicates full self-management and 0 indicates no self-management. The scale measures consumer behavior relating to core components in the IMR program. The scale includes parallel clinician and consumer versions. Participants participating in IMR groups for less than 10-12 months will attend fewer measuring times.
Baseline (0 months), 6 and 12 months.
The Illness Management Fidelity Scale
大体时间：Baseline (0 months), 6 and 12 months.
Assesses the degree of fidelity with 13 items on a 5-point Likert scale where 5 indicates full implementation and 0 indicates no implementation. Filled in by researchers on the basis of a semistructured interview with staff members.
Baseline (0 months), 6 and 12 months.
General Organizational Index
大体时间：Baseline (0 months), 6 and 12 months.
A 12-item scale measuring organizational outcome of implementation, on a 5-point Likert scale where 5 indicates full implementation and 0 indicates no implementation. The scale is filled in by researchers on the basis of a semi-structured interview with staff members.
Baseline (0 months), 6 and 12 months.
Attendance registration
大体时间：Baseline (0 months), 3, 6, 9 and 12 months.
The number of sessions the patients are attending in the IMR treatment group.
Baseline (0 months), 3, 6, 9 and 12 months.

其他结果措施

结果测量
措施说明
大体时间
Mapping the total number of patients identified receiving a psychosis-related diagnosis within the categories F 20-39 (ICD 10) for the years 2021-2023.
大体时间：End of treatment group, on average of 11 months.
The numbers will be displayed in the form of statistics obtained in the hospital. The numbers will be compared to what has been reported in the annual reports for the clinics from 2015 to 2020.
End of treatment group, on average of 11 months.

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

赞助

University Hospital, Akershus

调查人员

  • 首席研究员：Anne-Lise Holmesland, PhD、University Hospital, Akershus

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查，以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2021年3月9日

初级完成 (实际的)

2022年6月30日

研究完成 (实际的)

2022年6月30日

研究注册日期

首次提交

2021年2月14日

首先提交符合 QC 标准的

2021年2月26日

首次发布 (实际的)

2021年3月2日

研究记录更新

最后更新发布 (实际的)

2022年9月30日

上次提交的符合 QC 标准的更新

2022年9月29日

最后验证

2022年9月1日

更多信息

与本研究相关的术语

关键字

其他相关的 MeSH 术语

其他研究编号

  • 20/09657

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)？

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.

订阅